menu
    • menu

    Company profile for Plus Therapeutics

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PLUS THERAPEUTICS is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system. We are a publicly-traded company on Nasdaq (PSTV, an abbreviation of ‘POSITIVE’) with our headquarters in Austin, Texas and GMP-validated manufacturing facilities in San Antonio, Texas. The location of our operations provides us with many potential strategic advan...
    PLUS THERAPEUTICS is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system. We are a publicly-traded company on Nasdaq (PSTV, an abbreviation of ‘POSITIVE’) with our headquarters in Austin, Texas and GMP-validated manufacturing facilities in San Antonio, Texas. The location of our operations provides us with many potential strategic advantages, including proximity to world-class cancer institutions and researchers and the ability to qualify and apply for funding through the Cancer Prevention and Research Institute of Texas, or CPRIT.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Plus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4200 Marathon Blvd., Suite 200 Austin, TX 78756 USA
    Telephone
    Telephone
    +1.737.255.7194
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://plustherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/plustherapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/plustxinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Plus Therapeutics Secures Highmark Coverage for CNSide Assay
    Plus Therapeutics Secures Highmark Coverage for CNSide Assay

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267245/0/en/Plus-Therapeutics-Secures-Highmark-Coverage-for-CNSide-CSF-Assay-Expanding-Reimbursement-to-75-Million-Covered-Lives.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Radiotherapeutics Moment: Isotopes are Changing Cancer Treatment
    Radiotherapeutics Moment: Isotopes are Changing Cancer Treatment

    02 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/the-radiotherapeutics-moment-how-isotopes-are-changing-cancer-treatment

    BIOSPACE
    02 Apr 2026
    Share Share
    Plus Therapeutics Announces Reverse Stock Split
    Plus Therapeutics Announces Reverse Stock Split

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265358/0/en/Plus-Therapeutics-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Plus Therapeutics Appoints Ron Andrews to Board
    Plus Therapeutics Appoints Ron Andrews to Board

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262896/0/en/Plus-Therapeutics-Appoints-Diagnostics-and-Molecular-Diagnostics-Industry-Leader-Ron-Andrews-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Plus Therapeutics To Unveil CNSide Cost Savings Data At ISPOR
    Plus Therapeutics To Unveil CNSide Cost Savings Data At ISPOR

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258891/0/en/Plus-Therapeutics-to-Present-New-Analysis-at-ISPOR-Showing-CNSide-May-Reduce-Leptomeningeal-Metastases-Healthcare-Costs-by-40.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Plus Therapeutics Unveils Results 2025 & Milestones for REYOBIQ
    Plus Therapeutics Unveils Results 2025 & Milestones for REYOBIQ

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255139/0/en/Plus-Therapeutics-Reports-2025-Results-Business-Progress-and-2026-Anticipated-Milestones-for-REYOBIQ-Clinical-Program-and-CNSide-Commercial-Rollout.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search